The global synthetic biology market size is projected to reach USD 30.7 billion by 2026 from USD 9.5 billion in 2021, at a CAGR of 26.5% during the forecast period. Factors such as the increasing demand for synthetic genes and synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market are propelling the growth of this market. However, rising biosafety, biosecurity, and ethical concerns related to synthetic biology is likely to hamper the growth of this market.
The oligonucleotides and synthetic DNA segment is expected to grow at the highest rate during the forecast period. On the basis of tool, the synthetic biology market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids.In 2020, the oligonucleotides and synthetic DNA segment is expected to register the highest CAGR during the forecast period.
This can be attributed to factors such as the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications, such as pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes.
The genome engineering segment is expected to grow at the highest CAGR during the forecast period. On the basis of technology, the market is segmented into gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology. The genome engineering segment is expected to register the highest CAGR during the forecast period due to factors such as the increasing use of engineering technologies for manipulating complex genomes, growing therapeutics development for cancer and other diseases, and the increasing technological advances in CRISPR-toolbox and DNA synthesis technologies.
The medical applications segment is expected to grow at the highest CAGR during the forecast period. Based on application, the synthetic biology market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications.The medical applications segment is expected to register the highest CAGR during the forecast period.
Factors such as the extensive research on new and better treatments, coupled with the availability of huge private and public funding for the discovery of novel therapies, is the primary driver for the medical applications segment’s growth.
The Asia Pacific is projected to witness the highest growth during the forecast period. The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.In 2020, North America accounted for the largest share of the synthetic biology market.
However, the APAC region is expected to witness the highest growth during the forecast period owing to the growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support. Furthermore, the increasing focus on the Asia Pacific markets due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers.
The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side- 70%, and Demand Side - 30% • By Designation (Supply Side): Managers - 45%, CXOs and Directors - 30%, and Executives- 25% • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
Lists of Companies Profiled in the Report: • Thermo Fisher Scientific Inc. (US) • Merck KGaA (Germany) • Agilent Technologies, Inc. (US) • Novozymes A/S (Denmark) • Ginkgo Bioworks (US) • Amyris, Inc. (US) • Precigen, Inc. (US) • GenScript Biotech Corporation (China) • Twist Bioscience (US) • Synthetic Genomics, Inc. (US) • Codexis, Inc. (US) • Synthego Corporation (US) • Creative Enzymes (US) • Eurofins Scientific (Luxembourg) • Cyrus Biotechnology Inc. (US) • ATUM (US) • TeselaGen (US) • Arzeda (US) • Integrated DNA Technologies, Inc. (US) • New England Biolabs (US).
Research Coverage: This report provides a detailed picture of the synthetic biology market.It aims at estimating the size and future growth potential of the market across different segments, such as tool, technology, application, and region.
The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall synthetic biology market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
Our reports have been used by over 10K customers, including:
The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology...
The global Drug discovery services market is projected to reach USD 31.4 billion by 2026 from USD 16.1 billion in 2021, at a CAGR of 14.3% during the forecast period of 2021 to 2026. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing demand for outsourcing analytical testing services, initiatives for research...
The aptamers market valued at an estimated USD 151 million in 2021 and is projected to reach USD 342 million by 2026, at a CAGR of 17.7% during the forecast period. Growth of aptamers market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages...
The contract research organization (CRO) market is expected to reach US$ 88,835.19 million in 2028 from US$ 50,093.56 million in 2021; it is expected to grow at a CAGR of 8.5% from 2021 to 2028. The growth of the market is primarily attributed to the surge in R&D expenditures and outsourcing activities, and rise in the number of clinical...
The high throughput screening market was valued at US$ 28,255.71 million in 2028 from US$ 15,997.47 million in 2021. The market is estimated to grow with a CAGR of 8.5% from 2021 to 2028. Factors such as the increase in investment in research and development by the pharmaceutical and biotechnology industry and the introduction of technologically...
The protein binding assay market is expected to reach US$ 694.63 million by 2028 from US$ 340.14 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028. Surge in drug discovery activities and growing need to reduce the costs of drug discovery and development are among key factors driving the market growth. However, challenges...
The high throughput screening market was valued at US$ 28,255.71 million in 2028 from US$ 15,997.47 million in 2020. The market is estimated to grow with a CAGR of 8.5% from 2021 to 2028. Factors such as increase in investment in research and development by the pharmaceutical and biotechnology industry and the introduction of technologically...
The North America molecular quality controls market is expected to reach US$ 155.61 million by 2028 from US$ 75.79 million in 2021; it is estimated to grow at a CAGR of 10.8% from 2021 to 2028. Factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the...
The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026. Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases Microplate...
The global medical device and diagnostics contract research organization market is expected to reach US$ 20,336.08 million in 2028 from US$ 12,314.65 million in 2021. The market is estimated to grow with a CAGR of 7.4% from 2021 to 2028. Key factors driving the market such as increasing number of clinical trials worldwide and rise in adoption...
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.